Abstract

ObjectivesTo develop and pilot a tool to measure and improve pharmaceutical companies’ clinical trial data sharing policies and practices.DesignCross sectional descriptive analysis.SettingLarge pharmaceutical companies with novel drugs approved by the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A possible future for the pharmaceutical industry.
Peter Tolias
Personalized medicine | VOL. 11
Peter ToliasPeter Tolias
01 Nov 2014
Yours, Mine, Ours……data sharing in clinical research
Andrea P Marshall
Australian Critical Care | VOL. 30
Andrea P MarshallAndrea P Marshall
01 Sep 2017
Examining association between cohesion and diversity in collaboration networks of pharmaceutical clinical trials with drug approvals.
Gary Lin ... Jen Bernstein
Journal of the American Medical Informatics Association : JAMIA | VOL. 28
Gary Lin, et. al.Gary Lin ... Jen Bernstein
08 Nov 2020
PHP156 - How does a small or medium sized pharmaceutical company prepare for and navigate the scottish market?
C.A Hill ... M Harries
Value in Health | VOL. 18
C.A Hill, et. al.C.A Hill ... M Harries
01 May 2015
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
New WHO guidance can support transparent and informed engagement with the private sector
Kent Buse ... Monika Arora
BMJ | VOL. 385
Kent Buse, et. al.Kent Buse ... Monika Arora
29 May 2024
Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders
Matthew Limb
BMJ | VOL. 385
Matthew LimbMatthew Limb
29 May 2024
Sudan: Aid workers describe “bloodbath” in Darfur as hospitals are repeatedly attacked
Elisabeth Mahase
BMJ | VOL. 385
Elisabeth MahaseElisabeth Mahase
29 May 2024
US state classifies mifepristone and misoprostol as dangerous controlled substances
Janice Hopkins Tanne
BMJ | VOL. 385
Janice Hopkins TanneJanice Hopkins Tanne
29 May 2024
View more papers